e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Cardiovascular and metabolic consequences of sleep-disordered breathing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The impact of obstructive sleep apnea in case of acute coronary syndrome
G. Calcaianu (Mulhouse, France), E. Virot (Mulhouse, France), D. Bresson (Mulhouse, France), M. Calcaianu (Mulhouse, France), C. Iamandi (Mulhouse, France), D. Debieuvre (Mulhouse, France)
Source:
International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Session:
Cardiovascular and metabolic consequences of sleep-disordered breathing
Session type:
Thematic Poster
Number:
4315
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Calcaianu (Mulhouse, France), E. Virot (Mulhouse, France), D. Bresson (Mulhouse, France), M. Calcaianu (Mulhouse, France), C. Iamandi (Mulhouse, France), D. Debieuvre (Mulhouse, France). The impact of obstructive sleep apnea in case of acute coronary syndrome. 4315
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Effect of obstructive sleep apnoea on severity and short-term prognosis of acute coronary syndrome
Source: Eur Respir J 2015; 45: 419-427
Year: 2015
Predictors of obstructive sleep apnoea in patients admitted for acute coronary syndrome
Source: Eur Respir J , 49 (3) 1600550; DOI: 10.1183/13993003.00550-2016
Year: 2017
The impact of obstructive sleep apnea syndrome on cardiovascular system in children
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Association between obstructive sleep apnea syndrome and coronary atherosclerostic disease
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
A case of obstructive sleep apnea with brady-tachy syndrome
Source: International Congress 2019 – CCC Sleep and breathing disorders
Year: 2019
The influence of obesity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 295s
Year: 2002
The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Screening of sleep apnea syndrome in patients with acute coronary syndrome
Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Year: 2010
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
Myocardial alterations in asymptomatic patients with obstructive sleep apnea syndrome
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017
The association of chronic obstructive pulmonary disease and sleep apnea syndrome (overlap syndrome)
Source: Eur Respir J 2002; 20: Suppl. 38, 495s
Year: 2002
Cardiac arrythmias in chronic obstructive pulmonary disease and obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 645s
Year: 2006
Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Is obstructive sleep apnea syndrome a risk factor for pulmonary thromboemboli?
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Undiagnosed COPD and overlapping obstructive sleep apnoea in coronary heart disease
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
The impact of obstructive sleep apnoea on the aorta
Source: Eur Respir J 2015; 46: 532-544
Year: 2015
Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience
Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new?
Year: 2020
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
Predictors of obstructive sleep apnea syndrome and metabolic syndrome
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept